Matthew Laurens
Pediatric Infectious Diseases · Baltimore, MDNPI 1548310220
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,820 of the $2,088 with a category attached, or 87.2%. AstraZeneca accounts for 94.2% of it on its own, with 1 other manufacturer making up the rest.
Across 4 payments — averaging $521.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi Pasteur Inc.$121
Across 111 payments — averaging $7324.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biontech SE$813K
What the payments were for
- Consulting fees$1,82087%
- Travel & lodging$844%
- Food & beverage$1849%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $1,967 |
| Sanofi Pasteur Inc. | 1 | $121 |
How this compares
Too few pediatric infectious diseases providers in Marylandto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Baltimore
- Nadia Sam-AguduBaltimore$12K
- James CampbellBaltimore$4K
- Pranita TammaBaltimore$2K
- Nadine Peart AkindeleBaltimore$69
- Mark TravassosBaltimore$35
- Robert AnconaBaltimore$14
- Andrea BerryBaltimore$0
- Karen KotloffBaltimore$0
- Aaron MilstoneBaltimore$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.